Clinical trial

Effectiveness of Tricortin 1000 in Patients Affected by Chronic Low Back Pain

NCT04585334 · Fidia Farmaceutici s.p.a., Industry · Unknown status

Key facts

NCT number NCT04585334
Title Effectiveness of Tricortin 1000 in Patients Affected by Chronic Low Back Pain
Official title A Double Blind, Double Dummy, Multicenter, Randomized, Placebo- and Active-controlled Clinical Trial to Evaluate Effectiveness of Tricortin 1000 in Patients Affected by Chronic Low Back Pain
Lead sponsor Fidia Farmaceutici s.p.a., Industry
Status Unknown status
Phase Phase 4
Study type Interventional
Conditions Low Back Pain, Mechanical
Intervention type Drug
Interventions Tricortin 1000, Itami, Placebo
Enrollment 300
Start date Mar 25, 2019
Primary completion Dec 1, 2024
Completion Jan 1, 2025
First posted Oct 14, 2020
Last update posted Oct 27, 2023
Countries Italy

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies